Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor	GLUD1 GLUD2	2.64e-05	2	103	2	GO:0016639
GeneOntologyMolecularFunction	glutamate dehydrogenase [NAD(P)+] activity	GLUD1 GLUD2	2.64e-05	2	103	2	GO:0004353
GeneOntologyMolecularFunction	glutamate dehydrogenase (NAD+) activity	GLUD1 GLUD2	2.64e-05	2	103	2	GO:0004352
GeneOntologyMolecularFunction	glutamate dehydrogenase (NADP+) activity	GLUD1 GLUD2	2.64e-05	2	103	2	GO:0004354
GeneOntologyMolecularFunction	L-leucine binding	GLUD1 GLUD2	5.44e-04	7	103	2	GO:0070728
GeneOntologyMolecularFunction	zinc ion binding	CYLD EPRS1 TTF2 MYBBP1A POLR1A MYO9B KAT6A GATA6 SUV39H2 LIG3 PARP1 ZNF638 KMT2A	6.64e-04	891	103	13	GO:0008270
GeneOntologyCellularComponent	super elongation complex	AFF2 AFF1 AFF4	2.30e-06	6	103	3	GO:0032783
GeneOntologyCellularComponent	nuclear protein-containing complex	TTF2 MYBBP1A MIS18BP1 POLR1A AFF2 TAF1B GON4L PRPF38B TFIP11 CHD8 LIG3 CRNKL1 SINHCAF CFDP1 KMT2A AFF1 WDR12 TAF4B CPSF3 AFF4	1.10e-05	1377	103	20	GO:0140513
GeneOntologyCellularComponent	fibrillar center	RERG ARHGAP32 TCOF1 GON4L TAF4B AFF4	1.24e-04	156	103	6	GO:0001650
GeneOntologyCellularComponent	transcription elongation factor complex	TTF2 AFF2 AFF1 AFF4	1.68e-04	56	103	4	GO:0008023
GeneOntologyCellularComponent	nuclear chromosome	GON4L LIG3 PARP1 SINHCAF CFDP1 ETAA1 TOP2A	2.65e-04	254	103	7	GO:0000228
HumanPheno	Upper eyelid coloboma	POLR1A TCOF1 FREM1	1.67e-05	9	31	3	HP:0000636
Domain	TF_AF4/FMR2	AFF2 AFF1 AFF4	6.49e-07	4	103	3	IPR007797
Domain	AF-4	AFF2 AFF1 AFF4	6.49e-07	4	103	3	PF05110
Domain	ELFV_dehydrog_N	GLUD1 GLUD2	3.01e-05	2	103	2	PF02812
Domain	PARP_ZN_FINGER_1	LIG3 PARP1	3.01e-05	2	103	2	PS00347
Domain	-	LIG3 PARP1	3.01e-05	2	103	2	3.30.1740.10
Domain	Glu/Leu/Phe/Val_DH_C	GLUD1 GLUD2	3.01e-05	2	103	2	IPR006096
Domain	Glu/Leu/Phe/Val_DH_dimer_dom	GLUD1 GLUD2	3.01e-05	2	103	2	IPR006097
Domain	Glu/Leu/Phe/Val_DH	GLUD1 GLUD2	3.01e-05	2	103	2	IPR006095
Domain	ELFV_dehydrog	GLUD1 GLUD2	3.01e-05	2	103	2	PF00208
Domain	zf-PARP	LIG3 PARP1	3.01e-05	2	103	2	PF00645
Domain	NAD_bind_Glu_DH	GLUD1 GLUD2	3.01e-05	2	103	2	IPR033922
Domain	GLFV_DEHYDROGENASE	GLUD1 GLUD2	3.01e-05	2	103	2	PS00074
Domain	Znf_PARP	LIG3 PARP1	3.01e-05	2	103	2	IPR001510
Domain	ELFV_dehydrog	GLUD1 GLUD2	3.01e-05	2	103	2	SM00839
Domain	Glu/Leu/Phe/Val_DH_AS	GLUD1 GLUD2	3.01e-05	2	103	2	IPR033524
Domain	PARP_ZN_FINGER_2	LIG3 PARP1	3.01e-05	2	103	2	PS50064
Domain	FAM21	WASHC2C WASHC2A	3.01e-05	2	103	2	IPR027308
Domain	zf-PARP	LIG3 PARP1	3.01e-05	2	103	2	SM01336
Domain	Post-SET_dom	SUV39H2 NSD3 KMT2A	8.66e-05	16	103	3	IPR003616
Domain	PostSET	SUV39H2 NSD3 KMT2A	8.66e-05	16	103	3	SM00508
Domain	POST_SET	SUV39H2 NSD3 KMT2A	8.66e-05	16	103	3	PS50868
Domain	CAP-ZIP_m	WASHC2C WASHC2A	9.00e-05	3	103	2	PF15255
Domain	FAM21/CAPZIP	WASHC2C WASHC2A	9.00e-05	3	103	2	IPR029341
Domain	PHD	KAT6A NSD3 SHPRH KMT2A RAI1	1.33e-04	89	103	5	SM00249
Domain	Znf_PHD	KAT6A NSD3 SHPRH KMT2A RAI1	1.48e-04	91	103	5	IPR001965
Domain	ZF_PHD_2	KAT6A NSD3 SHPRH KMT2A RAI1	1.81e-04	95	103	5	PS50016
Domain	ZF_PHD_1	KAT6A NSD3 SHPRH KMT2A RAI1	1.90e-04	96	103	5	PS01359
Domain	SNF2_N	TTF2 CHD8 SHPRH	7.19e-04	32	103	3	IPR000330
Domain	SNF2_N	TTF2 CHD8 SHPRH	7.19e-04	32	103	3	PF00176
Domain	C2	UNC13B SYT17 RAB11FIP2 DYSF C2CD4C	7.95e-04	131	103	5	PF00168
Domain	C2	UNC13B SYT17 RAB11FIP2 DYSF C2CD4C	9.72e-04	137	103	5	SM00239
Domain	R3H	R3HCC1 NKRF	1.06e-03	9	103	2	SM00393
Domain	C2	UNC13B SYT17 RAB11FIP2 DYSF C2CD4C	1.14e-03	142	103	5	PS50004
Domain	HAT	CRNKL1 PDCD11	1.32e-03	10	103	2	SM00386
Domain	HAT	CRNKL1 PDCD11	1.32e-03	10	103	2	IPR003107
Domain	-	UNC13B SYT17 RAB11FIP2 DYSF C2CD4C	1.37e-03	148	103	5	2.60.40.150
Domain	SET	SUV39H2 NSD3 KMT2A	1.49e-03	41	103	3	PF00856
Domain	R3H	R3HCC1 NKRF	1.60e-03	11	103	2	PS51061
Domain	R3H	R3HCC1 NKRF	1.60e-03	11	103	2	PF01424
Domain	-	R3HCC1 NKRF	1.60e-03	11	103	2	3.30.1370.50
Domain	R3H_dom	R3HCC1 NKRF	1.60e-03	11	103	2	IPR001374
Domain	SET	SUV39H2 NSD3 KMT2A	2.08e-03	46	103	3	SM00317
Domain	C2_dom	UNC13B SYT17 RAB11FIP2 DYSF C2CD4C	2.15e-03	164	103	5	IPR000008
Domain	H15	KAT6A SHPRH	2.26e-03	13	103	2	SM00526
Domain	Lactamase_B	ELAC1 CPSF3	2.26e-03	13	103	2	PF00753
Domain	H15	KAT6A SHPRH	2.26e-03	13	103	2	PS51504
Domain	Histone_H1/H5_H15	KAT6A SHPRH	2.62e-03	14	103	2	IPR005818
Domain	SET_dom	SUV39H2 NSD3 KMT2A	2.65e-03	50	103	3	IPR001214
Domain	SET	SUV39H2 NSD3 KMT2A	2.65e-03	50	103	3	PS50280
Domain	Lactamase_B	ELAC1 CPSF3	3.02e-03	15	103	2	SM00849
Domain	RhoGAP	ARHGAP32 TAGAP MYO9B	4.87e-03	62	103	3	SM00324
Domain	RhoGAP	ARHGAP32 TAGAP MYO9B	5.09e-03	63	103	3	PF00620
Domain	RhoGAP_dom	ARHGAP32 TAGAP MYO9B	5.32e-03	64	103	3	IPR000198
Domain	RHOGAP	ARHGAP32 TAGAP MYO9B	5.32e-03	64	103	3	PS50238
Domain	-	ARHGAP32 TAGAP MYO9B	5.32e-03	64	103	3	1.10.555.10
Domain	-	ELAC1 CPSF3	5.36e-03	20	103	2	3.60.15.10
Domain	Metallo-B-lactamas	ELAC1 CPSF3	5.36e-03	20	103	2	IPR001279
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	EPRS1 MYBBP1A POLR1A GON4L KIF4A CHD8 EDC4 DENR NSD3 LIG3 PARP1 SHPRH ZNF638 PDCD11 KMT2A WDR12 TOP2A RAI1	1.75e-16	394	104	18	27248496
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EPRS1 TTF2 MYBBP1A WASHC2C TCOF1 MAP4 RPAP3 KIF4A PRPF38B TFIP11 EDC4 NKRF LIG3 PARP1 GLUD1 CFDP1 ZNF638 KMT2A CAMSAP2 CPSF3 TOP2A AFF4 VCPIP1	4.96e-15	934	104	23	33916271
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	EPRS1 TTF2 MYBBP1A TCOF1 GATA6 KIF4A TFIP11 NKRF NSD3 LIG3 ZNF106 PARP1 SINHCAF FAU RPL7L1 MORF4L2 ZNF638 PDCD11 KMT2A HADHB FUS CPSF3 TOP2A RAI1 VCPIP1	6.51e-14	1294	104	25	30804502
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	EPRS1 TTF2 MYBBP1A MIS18BP1 POLR1A MAP4 RPAP3 MYO9B TAF1B KIF4A TFIP11 CHD8 PGD NKRF LIG3 CRNKL1 PARP1 FAU RPL7L1 ZNF638 PDCD11 EXOC1 HADHB CPSF3 TOP2A	1.75e-13	1353	104	25	29467282
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYBBP1A POLR1A TCOF1 MAP4 KIF4A CHD8 EDC4 NKRF TASOR2 CRNKL1 LARP4B ZNF638 PDCD11 KMT2A WDR12 FUS CPSF3 RAI1	9.88e-13	653	104	18	22586326
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MIS18BP1 KAT6A KIF4A CHD8 SUV39H2 NSD3 LIG3 PARP1 MORF4L2 CFDP1 SHPRH KMT2A ZNF770 WDR12 TOP2A AFF4 RAI1	3.59e-12	608	104	17	36089195
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	EPRS1 MYBBP1A POLR1A WASHC2C TCOF1 TFIP11 NKRF NSD3 CRNKL1 FAU RPL7L1 ZNF638 PDCD11 KMT2A WDR12 HADHB FUS CPSF3 TOP2A	7.81e-12	847	104	19	35850772
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	EPRS1 TTF2 MYBBP1A TCOF1 MAP4 RPAP3 KIF4A TFIP11 CHD8 EDC4 NKRF NSD3 PDCD11 KMT2A TOP2A VCPIP1	8.85e-12	549	104	16	38280479
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CYLD MIS18BP1 GON4L KIF4A EDC4 NSD3 LIG3 MORF4L2 GLUD2 SHPRH ZNF638 KMT2A EXOC1 HADHB CPSF3 RAI1 VCPIP1	9.08e-12	645	104	17	25281560
Pubmed	Human transcription factor protein interaction networks.	CYLD ARHGAP32 MYBBP1A GATA6 GON4L TFIP11 CHD8 EDC4 WASHC2A NKRF LIG3 LARP4B SINHCAF FAU RPL7L1 MORF4L2 GLUD1 CFDP1 ZNF638 PDCD11 KMT2A ZNF770 HADHB	3.09e-11	1429	104	23	35140242
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	MYBBP1A MAP4 KIF4A TFIP11 CHD8 LIG3 PARP1 CFDP1 ZNF638 FUS TOP2A AFF4	5.93e-11	283	104	12	30585729
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	EPRS1 MYBBP1A MAP4 KIF4A TFIP11 CHD8 NKRF NSD3 TASOR2 LIG3 CRNKL1 PARP1 ZNF638 PDCD11 KMT2A FUS TOP2A AFF4 RAI1	5.95e-11	954	104	19	36373674
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	EPRS1 MYBBP1A POLR1A TCOF1 MAP4 PRPF38B TFIP11 CHD8 NKRF CRNKL1 PARP1 FAU RPL7L1 GLUD1 PDCD11 KMT2A WDR12 HADHB FUS CPSF3 TOP2A	3.07e-10	1318	104	21	30463901
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	EPRS1 MYBBP1A POLR1A TCOF1 MAP4 EDC4 ZNF638 PDCD11 KMT2A ATP2B3	5.67e-10	202	104	10	24639526
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	EPRS1 MYBBP1A TCOF1 MAP4 MYO9B KIF4A PRPF38B TFIP11 NKRF LIG3 CRNKL1 PARP1 FAU GLUD1 AFF1 HADHB FUS CAMSAP2 TOP2A AFF4	7.74e-10	1247	104	20	27684187
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	MYBBP1A TCOF1 KIF4A TFIP11 NKRF ZNF106 PARP1 SINHCAF FAU RPL7L1 ZNF638 PDCD11 WDR12 HADHB FUS CPSF3 TOP2A AFF4	8.45e-10	989	104	18	36424410
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MYBBP1A MIS18BP1 POLR1A MAP4 KIF4A PRPF38B CHD8 PGD NKRF NSD3 LIG3 CRNKL1 PARP1 ZNF532 CFDP1 KMT2A CPSF3 TOP2A	1.25e-09	1014	104	18	32416067
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	EPRS1 MYBBP1A POLR1A TCOF1 MAP4 MYO9B EDC4 NKRF LIG3 CRNKL1 PARP1 RPL7L1 GLUD1 ZNF638 PDCD11 HADHB FUS TOP2A	1.46e-09	1024	104	18	24711643
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	EPRS1 MYBBP1A TCOF1 MAP4 PRPF38B TFIP11 NKRF CRNKL1 PARP1 FAU RPL7L1 PDCD11 WDR12 FUS TOP2A	5.06e-09	731	104	15	29298432
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	EPRS1 MYBBP1A MAP4 RPAP3 EDC4 NKRF NSD3 TASOR2 CRNKL1 PARP1 LARP4B RPL7L1 GLUD1 ZNF638 PDCD11 WDR12 HADHB FUS TOP2A	5.70e-09	1257	104	19	36526897
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	MYBBP1A TCOF1 TFIP11 CHD8 EDC4 NKRF LIG3 CRNKL1 ZNF638 KMT2A AFF4	6.79e-09	341	104	11	32971831
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TRPM6 EPRS1 MYBBP1A POLR1A TCOF1 MAP4 EDC4 PGD LIG3 CRNKL1 PARP1 RPL7L1 GLUD1 PDCD11 WDR12 HADHB FUS ATP2B3 CPSF3 TOP2A	7.46e-09	1425	104	20	30948266
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	MYBBP1A POLR1A MAP4 MYO9B TAF1B KAT6A KIF4A NKRF LIG3 LARP4B RPL7L1 MORF4L2 PDCD11 WDR12 TOP2A	8.36e-09	759	104	15	35915203
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	LDLRAP1 TTF2 NRG1 MYBBP1A KIF4A CHD8 EDC4 PARP1 ZNF638 EXOC1 FUS CPSF3 TOP2A	2.15e-08	582	104	13	20467437
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MYBBP1A TCOF1 PRPF38B TFIP11 NKRF NSD3 LIG3 CRNKL1 PARP1 FAU ZNF532 PTPRO MORF4L2 ZNF638 HADHB CPSF3 AFF4	2.28e-08	1082	104	17	38697112
Pubmed	AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).	KMT2A AFF1 AFF4	2.60e-08	3	104	3	10588740
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	EPRS1 MYBBP1A TCOF1 TFIP11 NKRF LIG3 PARP1 ZNF638 PDCD11 KMT2A FUS TOP2A RAI1	3.39e-08	605	104	13	28977666
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CYLD EPRS1 ARHGAP32 WASHC2C MAP4 RAB11FIP2 PRPF38B EDC4 WASHC2A LARP4B FAU GLUD1 GLUD2 EXOC1 HADHB CAMSAP2 VCPIP1	4.79e-08	1139	104	17	36417873
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	EPRS1 TCOF1 MAP4 EDC4 LIG3 PARP1 MORF4L2 ZNF638 FUS TOP2A	8.09e-08	340	104	10	24332808
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	POLR1A MAP4 GON4L KIF4A PRPF38B TFIP11 CHD8 EDC4 NKRF NSD3 CRNKL1 LARP4B RPL7L1 MORF4L2 PDCD11 KMT2A WDR12 CAMSAP2 AFF4	9.08e-08	1497	104	19	31527615
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	EPRS1 ARHGAP32 MYBBP1A MAP4 PGD NKRF TASOR2 CRNKL1 PARP1 LARP4B HADHB FUS	1.02e-07	551	104	12	34728620
Pubmed	AF4 uses the SL1 components of RNAP1 machinery to initiate MLL fusion- and AEP-dependent transcription.	TAF1B KMT2A AFF1	1.04e-07	4	104	3	26593443
Pubmed	Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice.	AFF2 AFF1 AFF4	1.04e-07	4	104	3	11923441
Pubmed	Mediation of Af4 protein function in the cerebellum by Siah proteins.	AFF2 AFF1 AFF4	1.04e-07	4	104	3	15459319
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	UNC13B EPRS1 MYBBP1A TCOF1 MAP4 TAF1B PRPF38B TFIP11 DENR NKRF CRNKL1 PARP1 LARP4B PDCD11 KMT2A WDR12 HADHB AFF4	1.26e-07	1371	104	18	36244648
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	MYBBP1A TCOF1 KIF4A TFIP11 CHD8 TASOR2 PARP1 ZNF638 TOP2A	1.34e-07	271	104	9	32433965
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TRPM6 CYLD EPRS1 MYBBP1A WASHC2C MAP4 TAGAP GATA6 TFIP11 WASHC2A LARP4B SINHCAF EML5 ZNF638 AFF1 AFF4	1.44e-07	1084	104	16	11544199
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	MYBBP1A CHD8 NKRF TASOR2 LIG3 CRNKL1 LARP4B MORF4L2 ZNF638 KMT2A TOP2A	1.73e-07	469	104	11	27634302
Pubmed	The interactome of CLUH reveals its association to SPAG5 and its co-translational proximity to mitochondrial proteins.	TCOF1 MAP4 LIG3 ZNF106 GLUD1 GLUD2 FUS TOP2A	1.87e-07	203	104	8	35012549
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	EPRS1 TTF2 MYBBP1A TCOF1 MAP4 NKRF CRNKL1 PARP1 LARP4B FAU MORF4L2 PDCD11 HADHB FUS CPSF3	2.07e-07	971	104	15	33306668
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	NRG1 POLR1A TFIP11 DYSF CRNKL1 ZNF106 VPS13D SHPRH KMT2A WDR12 RAI1	3.07e-07	497	104	11	36774506
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	EPRS1 MYBBP1A TCOF1 MAP4 RPAP3 NKRF PARP1 FAU ZNF638 HADHB CPSF3 TOP2A	3.31e-07	615	104	12	31048545
Pubmed	Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.	MYBBP1A TCOF1 LIG3 PARP1 GLUD1 GLUD2 PDCD11 HADHB	4.23e-07	226	104	8	37839992
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	TTF2 MYBBP1A MIS18BP1 RPAP3 GATB C2CD4C NKRF PARP1 LARP4B VPS13D FAU RPL7L1 GLUD1 PDCD11 WDR12 HADHB TOP2A VCPIP1	4.53e-07	1496	104	18	32877691
Pubmed	Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex.	MYBBP1A TCOF1 MAP4 MYO9B WDR12 HADHB AFF4	4.71e-07	156	104	7	22952844
Pubmed	The histone acetyltransferase KAT6A is recruited to unmethylated CpG islands via a DNA binding winged helix domain.	POLR1A KAT6A NKRF FAU RPL7L1 MORF4L2 GLUD1 SHPRH TOP2A AFF4	5.28e-07	417	104	10	36537216
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	EPRS1 MYBBP1A WASHC2C TCOF1 MAP4 PRPF38B TFIP11 ZNF106 ZNF638 KMT2A AFF1 TOP2A VCPIP1	5.66e-07	774	104	13	15302935
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	EPRS1 WASHC2C MAP4 KIF4A CHD8 EDC4 PARP1 ZNF638 TOP2A	7.33e-07	332	104	9	32786267
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	MYBBP1A MIS18BP1 TFIP11 CHD8 CRNKL1 RPL7L1 PDCD11 KMT2A FUS	8.71e-07	339	104	9	30415952
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	EPRS1 TCOF1 MAP4 KIF4A NKRF LIG3 PARP1 MORF4L2 FUS TOP2A	8.76e-07	441	104	10	31239290
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	MYBBP1A TCOF1 MAP4 NKRF CRNKL1 PARP1 LARP4B FAU RPL7L1 ZNF638 PDCD11 FUS TOP2A	9.02e-07	807	104	13	22681889
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	PRPF38B TFIP11 CHD8 PARP1 ZNF638 KMT2A CPSF3 TOP2A	9.33e-07	251	104	8	31076518
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	EPRS1 MYBBP1A TCOF1 MAP4 RPAP3 KIF4A TFIP11 CRNKL1 PARP1 FAU MORF4L2 GLUD1 ZNF638 HADHB FUS TOP2A VCPIP1	1.00e-06	1415	104	17	28515276
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	TTF2 MYBBP1A NKRF LIG3 PARP1 LARP4B PDCD11 WDR12 RAI1	1.11e-06	349	104	9	25665578
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CYLD TCOF1 KAT6A CHD8 NKRF BRWD3 NSD3 LARP4B FAU EML5 MORF4L2 TAF4B TOP2A AFF4 RAI1	1.19e-06	1116	104	15	31753913
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	EPRS1 MYBBP1A TAF1B GATB SFMBT2 TASOR2 CREBRF PARP1 GLUD1 GLUD2 KMT2A HADHB FUS CAMSAP2 ATP2B3 TOP2A RAI1	1.30e-06	1442	104	17	35575683
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	MYBBP1A PRPF38B TFIP11 NKRF LARP4B FAU RPL7L1 ZNF638 WDR12 FUS CPSF3 TOP2A	1.56e-06	713	104	12	29802200
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	LDLRAP1 MAP4 KIF4A TFIP11 CHD8 NKRF NSD3 LIG3 ZNF638	1.79e-06	370	104	9	22922362
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	MYBBP1A POLR1A NKRF PARP1 RPL7L1 ZNF638 PDCD11 WDR12 HADHB TOP2A	1.98e-06	483	104	10	36912080
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	TTF2 MYBBP1A MAP4 MYO9B LIG3 PARP1 LARP4B RPL7L1 PDCD11 WDR12	2.09e-06	486	104	10	30940648
Pubmed	Ethanol-induced conditioned taste aversion in BXD recombinant inbred mice.	PARP1 GLUD1 GLUD2	2.15e-06	9	104	3	9756038
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	ARHGAP32 MYBBP1A POLR1A PRPF38B TASOR2 LRRC53 WDR12 TAF4B TOP2A AFF4	2.51e-06	496	104	10	31343991
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	EPRS1 MYBBP1A WASHC2C TCOF1 MAP4 KIF4A CHD8 LARP4B ZNF638 TOP2A	2.84e-06	503	104	10	16964243
Pubmed	The ubiquitin E3 ligase ARIH1 regulates hnRNP E1 protein stability, EMT and breast cancer progression.	CYLD EPRS1 MAP4 PARP1 TOP2A	2.97e-06	74	104	5	35102251
Pubmed	A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.	KMT2A AFF1 AFF4	3.07e-06	10	104	3	20153263
Pubmed	[Detection of fusion genes resulting from chromosome abnormalities in childhood acute lymphoblastic leukemia].	KMT2A AFF1 FUS	3.07e-06	10	104	3	16215946
Pubmed	The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.	POLR1A GATB PGD LIG3 PARP1 LARP4B RPL7L1 FUS TOP2A	3.38e-06	400	104	9	35013556
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	MYBBP1A MIS18BP1 MAP4 KIF4A ZNF638 KMT2A TOP2A	3.43e-06	210	104	7	16565220
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	EPRS1 MYBBP1A EDC4 NKRF CRNKL1 PARP1 PDCD11 WDR12 HADHB FUS CPSF3	3.47e-06	638	104	11	33239621
Pubmed	Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.	MYBBP1A MAP4 NKRF TASOR2 ZNF106 FAU PDCD11 TOP2A RAI1	3.59e-06	403	104	9	35253629
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	EPRS1 MYBBP1A TCOF1 PGD NKRF CRNKL1 PARP1 FAU PDCD11 HADHB TOP2A	3.62e-06	641	104	11	36057605
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	EPRS1 MYBBP1A POLR1A TCOF1 MAP4 NKRF CRNKL1 PARP1 RPL7L1 PDCD11 FUS CPSF3 TOP2A	5.31e-06	949	104	13	36574265
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	EPRS1 TTF2 MAP4 KIF4A PRPF38B CHD8 EDC4 PARP1 KMT2A ZNF770 HADHB FUS TOP2A RAI1	5.37e-06	1103	104	14	34189442
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	EPRS1 TTF2 MYBBP1A TCOF1 MAP4 EDC4 DENR NKRF PARP1 EXOC1 HADHB FUS	5.65e-06	809	104	12	32129710
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	MYBBP1A TCOF1 ZNF638 FUS TOP2A AFF4	5.77e-06	148	104	6	32538781
Pubmed	TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.	NKRF PARP1 FAU RPL7L1 PDCD11 WDR12 HADHB FUS TOP2A	6.05e-06	430	104	9	38172120
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	MYBBP1A TASOR2 ZNF638 KMT2A TOP2A	6.23e-06	86	104	5	37253089
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	UNC13B CYLD LDLRAP1 EPRS1 TCOF1 TFIP11 BRWD3 CRNKL1 PARP1 ZNF532 MORF4L2 GLUD1 EXOC1 AFF4 VCPIP1	6.59e-06	1285	104	15	35914814
Pubmed	TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas.	PGD LIG3 PARP1 GLUD1 FUS TOP2A	6.73e-06	152	104	6	28192407
Pubmed	A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.	EPRS1 GATA6 GON4L SUV39H2 FREM1 CRNKL1 ACSM4 KMT2A	7.21e-06	331	104	8	19490893
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	MYBBP1A POLR1A TCOF1 CHD8 NKRF PARP1 LARP4B FUS TOP2A	7.28e-06	440	104	9	34244565
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	EDC4 NKRF CRNKL1 LARP4B ZNF638 PDCD11 WDR12 TOP2A	7.37e-06	332	104	8	25693804
Pubmed	Oncogenic ZMYND11-MBTD1 fusion protein anchors the NuA4/TIP60 histone acetyltransferase complex to the coding region of active genes.	TFIP11 MORF4L2 KMT2A TOP2A	7.74e-06	42	104	4	35705031
Pubmed	Spatial Chromosome Folding and Active Transcription Drive DNA Fragility and Formation of Oncogenic MLL Translocations.	KMT2A TOP2A	8.86e-06	2	104	2	31202576
Pubmed	Stress response in periodontal ligament stem cells may contribute to bisphosphonate‑associated osteonecrosis of the jaw: A gene expression array analysis.	CYLD PARP1	8.86e-06	2	104	2	32705175
Pubmed	Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias.	KMT2A AFF1	8.86e-06	2	104	2	9326653
Pubmed	Critical role of the cysteine 323 residue in the catalytic activity of human glutamate dehydrogenase isozymes.	GLUD1 GLUD2	8.86e-06	2	104	2	15750346
Pubmed	Molecular cloning, structure and expression analysis of a full-length mouse brain glutamate dehydrogenase cDNA.	GLUD1 GLUD2	8.86e-06	2	104	2	1711373
Pubmed	Glutamate Delta-1 Receptor Regulates Inhibitory Neurotransmission in the Nucleus Accumbens Core and Anxiety-Like Behaviors.	GLUD1 GLUD2	8.86e-06	2	104	2	34173171
Pubmed	Glutamate dehydrogenase is essential to sustain neuronal oxidative energy metabolism during stimulation.	GLUD1 GLUD2	8.86e-06	2	104	2	28621566
Pubmed	GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior.	GLUD1 GLUD2	8.86e-06	2	104	2	32078638
Pubmed	Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate.	GLUD1 GLUD2	8.86e-06	2	104	2	20529287
Pubmed	The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage.	PARP1 FUS	8.86e-06	2	104	2	23833192
Pubmed	The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression.	KMT2A AFF1	8.86e-06	2	104	2	16169901
Pubmed	Development of mice with brain-specific deletion of floxed glud1 (glutamate dehydrogenase 1) using cre recombinase driven by the nestin promoter.	GLUD1 GLUD2	8.86e-06	2	104	2	23595828
Pubmed	Distinct roles of two SEC scaffold proteins, AFF1 and AFF4, in regulating RNA polymerase II transcription elongation.	AFF1 AFF4	8.86e-06	2	104	2	37528066
Pubmed	Determination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry).	GLUD1 GLUD2	8.86e-06	2	104	2	25124006
Pubmed	Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase.	GLUD1 GLUD2	8.86e-06	2	104	2	23673664
Pubmed	Protein Tyrosine Phosphatase Receptor Type J (PTPRJ) Regulates Retinal Axonal Projections by Inhibiting Eph and Abl Kinases in Mice.	PTPRJ PTPRO	8.86e-06	2	104	2	30082414
Pubmed	Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer.	PARP1 CHFR	8.86e-06	2	104	2	26356822
Interaction	H2BC21 interactions	EPRS1 TAF1B KAT6A KIF4A CHD8 SFMBT2 NSD3 LIG3 PARP1 SINHCAF MORF4L2 CFDP1 HEATR9 SHPRH ZNF638 KMT2A FUS ATP2B3 TOP2A RAI1	3.12e-10	696	103	20	int:H2BC21
Interaction	NAA40 interactions	EPRS1 TTF2 MYBBP1A WASHC2C TCOF1 MAP4 RPAP3 KIF4A PRPF38B TFIP11 EDC4 NKRF LIG3 PARP1 GLUD1 CFDP1 ZNF638 KMT2A CAMSAP2 CPSF3 TOP2A AFF4 VCPIP1	6.10e-10	978	103	23	int:NAA40
Interaction	H2AC4 interactions	EPRS1 MYBBP1A POLR1A GON4L CHD8 EDC4 LIG3 PARP1 CFDP1 SHPRH ZNF638 PDCD11 KMT2A WDR12 ATP2B3 TOP2A RAI1	7.53e-10	506	103	17	int:H2AC4
Interaction	POLR1G interactions	MYBBP1A POLR1A TCOF1 RPAP3 KAT6A CHD8 NKRF NSD3 LIG3 ZNF106 CFDP1 PDCD11 KMT2A TOP2A AFF4 RAI1	3.65e-09	489	103	16	int:POLR1G
Interaction	SIRT7 interactions	MYBBP1A POLR1A TCOF1 MAP4 KIF4A CHD8 EDC4 NKRF TASOR2 CRNKL1 LARP4B ZNF638 PDCD11 KMT2A WDR12 FUS CPSF3 TOP2A RAI1	6.36e-09	744	103	19	int:SIRT7
Interaction	H3-3A interactions	EPRS1 KAT6A KIF4A CHD8 SUV39H2 BRWD3 NSD3 LIG3 PARP1 MORF4L2 CFDP1 SHPRH KMT2A ZNF770 HADHB FUS TOP2A AFF4 RAI1	7.09e-09	749	103	19	int:H3-3A
Interaction	MEN1 interactions	EPRS1 MYBBP1A WASHC2C TCOF1 TFIP11 CHD8 EDC4 NKRF NSD3 LIG3 CRNKL1 FAU RPL7L1 ZNF638 PDCD11 KMT2A WDR12 HADHB FUS CPSF3 TOP2A AFF4	8.82e-09	1029	103	22	int:MEN1
Interaction	CIT interactions	CYLD ARHGAP32 MYBBP1A POLR1A TCOF1 RPAP3 MYO9B ZC2HC1B PRPF38B TFIP11 CHD8 EDC4 NKRF LIG3 CRNKL1 LARP4B RPL7L1 MORF4L2 GLUD1 ZNF638 PDCD11 KMT2A WDR12 HADHB FUS TOP2A	1.17e-08	1450	103	26	int:CIT
Interaction	NPM1 interactions	CYLD EPRS1 MYBBP1A MYO9B KAT6A CHD8 EDC4 NKRF CRNKL1 PARP1 LARP4B FAU RPL7L1 GLUD2 ZNF638 PDCD11 KMT2A AFF1 ZNF770 WDR12 FUS CPSF3 TOP2A	2.97e-08	1201	103	23	int:NPM1
Interaction	ZNF330 interactions	MYBBP1A KIF4A NKRF NSD3 LIG3 ZNF106 PARP1 CFDP1 SHPRH PDCD11 KMT2A TOP2A AFF4 RAI1	6.31e-08	446	103	14	int:ZNF330
Interaction	LGR4 interactions	EPRS1 NRG1 MYBBP1A POLR1A TCOF1 MAP4 EDC4 ZNF638 PDCD11 KMT2A ATP2B3	1.01e-07	262	103	11	int:LGR4
Interaction	DOT1L interactions	EPRS1 MYBBP1A POLR1A TCOF1 TFIP11 NKRF NSD3 CRNKL1 FAU RPL7L1 ZNF638 PDCD11 KMT2A AFF1 WDR12 HADHB CPSF3 TOP2A	1.30e-07	807	103	18	int:DOT1L
Interaction	H2BC3 interactions	CYLD EPRS1 POLR1A GON4L KIF4A CHD8 EDC4 DENR NSD3 LIG3 PARP1 KMT2A RAI1	1.54e-07	406	103	13	int:H2BC3
Interaction	HECTD1 interactions	EPRS1 MYBBP1A POLR1A MAP4 MYO9B TAF1B KAT6A KIF4A PRPF38B NKRF LIG3 PARP1 LARP4B RPL7L1 MORF4L2 PDCD11 WDR12 EXOC1 TOP2A	5.11e-07	984	103	19	int:HECTD1
Interaction	SMC5 interactions	EPRS1 MYBBP1A MAP4 KIF4A TFIP11 CHD8 NKRF NSD3 TASOR2 LIG3 CRNKL1 PARP1 ZNF638 PDCD11 KMT2A FUS TOP2A AFF4 RAI1	6.52e-07	1000	103	19	int:SMC5
Interaction	UHRF2 interactions	MYBBP1A KIF4A CHD8 TASOR2 LIG3 PARP1 ZNF638 KMT2A TOP2A	8.75e-07	200	103	9	int:UHRF2
Interaction	H1-4 interactions	CYLD EPRS1 MYBBP1A TCOF1 TAF1B EDC4 NKRF BRWD3 TASOR2 RPL7L1 ZNF638 PDCD11 KMT2A ZNF770 WDR12	1.20e-06	656	103	15	int:H1-4
Interaction	MYCN interactions	EPRS1 MYBBP1A POLR1A TCOF1 PRPF38B TFIP11 NKRF LIG3 CRNKL1 ZNF106 PARP1 SINHCAF FAU RPL7L1 MORF4L2 ZNF638 PDCD11 KMT2A HADHB FUS CPSF3 RAI1	1.33e-06	1373	103	22	int:MYCN
Interaction	H3C3 interactions	MIS18BP1 KIF4A CHD8 NSD3 LIG3 PARP1 MORF4L2 SHPRH KMT2A WDR12 TOP2A AFF4 RAI1	1.45e-06	495	103	13	int:H3C3
Interaction	POLR1E interactions	MYBBP1A POLR1A TCOF1 RPAP3 CHD8 NKRF ZNF106 PARP1 PDCD11 KMT2A CPSF3	1.78e-06	350	103	11	int:POLR1E
Interaction	OBSL1 interactions	ARHGAP32 MYBBP1A POLR1A TCOF1 PRPF38B EDC4 NKRF TASOR2 CRNKL1 PARP1 RPL7L1 LRRC53 ZNF638 PDCD11 WDR12 FUS TOP2A	3.06e-06	902	103	17	int:OBSL1
Interaction	CSNK2A2 interactions	POLR1A TCOF1 TAF1B KAT6A BRWD3 TTLL7 ZNF106 PARP1 RPL7L1 CFDP1 KMT2A WDR12 HADHB CAMSAP2 TOP2A	3.63e-06	718	103	15	int:CSNK2A2
Interaction	CENPA interactions	MIS18BP1 KAT6A KIF4A NSD3 LIG3 PARP1 SHPRH PDCD11 KMT2A TOP2A RAI1	3.63e-06	377	103	11	int:CENPA
Interaction	RPL3 interactions	CYLD MYBBP1A TAF1B KAT6A NKRF PARP1 SINHCAF RPL7L1 ETAA1 PDCD11 KMT2A ZNF770 WDR12 TOP2A RAI1	3.88e-06	722	103	15	int:RPL3
Interaction	SNRNP40 interactions	MIS18BP1 TCOF1 KAT6A GON4L TFIP11 NKRF NSD3 TASOR2 CRNKL1 ZNF532 PDCD11 KMT2A FUS TOP2A	4.44e-06	637	103	14	int:SNRNP40
Interaction	MIR93 interactions	EPRS1 EDC4 ZNF106 ETAA1 PDCD11 FUS	4.85e-06	85	103	6	int:MIR93
Interaction	BMI1 interactions	MYBBP1A GATA6 TFIP11 EDC4 NKRF CRNKL1 PARP1 LARP4B ZNF638 PDCD11 KMT2A WDR12 FUS TOP2A	6.54e-06	659	103	14	int:BMI1
Interaction	MECP2 interactions	MYBBP1A TCOF1 TAF1B PRPF38B TFIP11 NKRF NSD3 LIG3 CRNKL1 PARP1 FAU ZNF532 PTPRO MORF4L2 ZNF638 PDCD11 HADHB FUS CPSF3 AFF4	6.94e-06	1287	103	20	int:MECP2
Interaction	NR2C2 interactions	EPRS1 MYBBP1A POLR1A TCOF1 MAP4 PRPF38B TFIP11 CHD8 NKRF CRNKL1 PARP1 FAU RPL7L1 GLUD1 PDCD11 KMT2A WDR12 HADHB FUS CPSF3 TOP2A	7.01e-06	1403	103	21	int:NR2C2
Interaction	MIR200C interactions	EPRS1 EDC4 ETAA1 PDCD11 FUS ELAC1	7.22e-06	91	103	6	int:MIR200C
Interaction	ADARB1 interactions	MYBBP1A TCOF1 TAF1B KIF4A TFIP11 CHD8 NKRF RPL7L1 ZNF638 PDCD11 ZNF770 TOP2A	7.53e-06	489	103	12	int:ADARB1
Interaction	H2BC8 interactions	MIS18BP1 GON4L KIF4A CHD8 NSD3 LIG3 PARP1 MORF4L2 CFDP1 KMT2A FUS TOP2A RAI1	7.55e-06	576	103	13	int:H2BC8
Interaction	PARP1 interactions	CYLD POLR1A GATB KIF4A PGD NKRF NSD3 LIG3 ZNF106 PARP1 LARP4B RPL7L1 GLUD1 CHFR SHPRH PDCD11 FUS TOP2A AFF4 RAI1	9.65e-06	1316	103	20	int:PARP1
Interaction	ARL4D interactions	EPRS1 MYBBP1A TCOF1 KIF4A TASOR2 ZNF638 VCPIP1	1.01e-05	146	103	7	int:ARL4D
Interaction	YAP1 interactions	EPRS1 TTF2 TCOF1 MAP4 RPAP3 RBPJL KIF4A TFIP11 CHD8 EDC4 NKRF NSD3 PARP1 MYO3B KMT2A HADHB FUS VCPIP1	1.01e-05	1095	103	18	int:YAP1
Interaction	NIFK interactions	MYBBP1A TCOF1 TAF1B KAT6A NKRF ZNF106 RPL7L1 PDCD11 ZNF770 WDR12 AFF4	1.29e-05	431	103	11	int:NIFK
Interaction	RPL13 interactions	CYLD MYBBP1A TAF1B KAT6A NKRF FAU RPL7L1 ZNF638 PDCD11 KMT2A ZNF770 WDR12 TOP2A RAI1	1.29e-05	700	103	14	int:RPL13
Interaction	H3C1 interactions	EPRS1 MYBBP1A TAF1B KAT6A KIF4A CHD8 SUV39H2 NSD3 LIG3 PARP1 CFDP1 SHPRH ZNF638 KMT2A TOP2A AFF4	1.30e-05	901	103	16	int:H3C1
Interaction	HMGN5 interactions	KAT6A LIG3 PARP1 GLUD1 KMT2A TOP2A RAI1	1.42e-05	154	103	7	int:HMGN5
Interaction	PYHIN1 interactions	TTF2 TCOF1 TFIP11 NKRF LIG3 PARP1 RPL7L1 WDR12 TOP2A RAI1	1.51e-05	358	103	10	int:PYHIN1
Interaction	POLR1A interactions	MYBBP1A POLR1A TCOF1 RPAP3 TAF1B KAT6A PARP1 SHPRH	1.73e-05	220	103	8	int:POLR1A
Interaction	NUP43 interactions	MIS18BP1 MAP4 GON4L CHD8 NKRF NSD3 TASOR2 LIG3 ZNF532 PDCD11 KMT2A FUS TOP2A	1.79e-05	625	103	13	int:NUP43
Interaction	IRF2 interactions	TASOR2 LIG3 PARP1 LARP4B FAU KMT2A	1.83e-05	107	103	6	int:IRF2
Interaction	H3-4 interactions	EPRS1 TAF1B RAB11FIP2 KAT6A NSD3 PARP1 EML5 KMT2A AFF1 TAF4B TOP2A	1.84e-05	448	103	11	int:H3-4
Interaction	FBXO22 interactions	CYLD NRG1 POLR1A TFIP11 DYSF CRNKL1 ZNF106 VPS13D SHPRH KMT2A WDR12 RAI1	2.02e-05	540	103	12	int:FBXO22
Interaction	H2AZ1 interactions	KAT6A CHD8 LIG3 PARP1 FAU MORF4L2 CFDP1 TOP2A AFF4 RAI1	2.04e-05	371	103	10	int:H2AZ1
Interaction	CHD4 interactions	EPRS1 MYBBP1A TCOF1 KAT6A TFIP11 NKRF LIG3 CRNKL1 PARP1 SHPRH ZNF638 PDCD11 KMT2A FUS TOP2A RAI1	2.13e-05	938	103	16	int:CHD4
Interaction	TERF2IP interactions	KIF4A CHD8 NSD3 TASOR2 LIG3 PARP1 CFDP1 ZNF638 KMT2A TOP2A AFF4 RAI1	2.51e-05	552	103	12	int:TERF2IP
Interaction	FZR1 interactions	CYLD EPRS1 TTF2 ARHGAP32 MYBBP1A TCOF1 MAP4 CHD8 NKRF CRNKL1 PARP1 LARP4B FAU MORF4L2 PDCD11 HADHB FUS CPSF3	2.51e-05	1172	103	18	int:FZR1
Interaction	DDX23 interactions	MYBBP1A TCOF1 TFIP11 NKRF LIG3 ZNF638 PDCD11 FUS CPSF3 TOP2A AFF4	3.46e-05	480	103	11	int:DDX23
Interaction	RPS6 interactions	CYLD MYBBP1A KAT6A NKRF NSD3 LIG3 ZNF106 FAU RPL7L1 CFDP1 PDCD11 ZNF770 WDR12 HADHB TOP2A	3.70e-05	874	103	15	int:RPS6
Interaction	ZC3H18 interactions	EPRS1 MYBBP1A TCOF1 MAP4 PRPF38B TFIP11 NKRF CRNKL1 PARP1 FAU RPL7L1 PDCD11 WDR12 FUS TOP2A	3.85e-05	877	103	15	int:ZC3H18
Interaction	PRKRA interactions	MYBBP1A TCOF1 TAF1B KAT6A NKRF RPL7L1 PDCD11 KMT2A ZNF770 WDR12	3.88e-05	400	103	10	int:PRKRA
Interaction	NKX2-1 interactions	GATA6 PGD LIG3 PARP1 GLUD1 FUS TOP2A	3.89e-05	180	103	7	int:NKX2-1
Interaction	BIRC3 interactions	EPRS1 MYBBP1A POLR1A TCOF1 MAP4 EDC4 PGD LIG3 CRNKL1 PARP1 RPL7L1 GLUD1 PDCD11 WDR12 HADHB FUS ATP2B3 CPSF3 TOP2A	4.09e-05	1334	103	19	int:BIRC3
Interaction	GRK5 interactions	MYBBP1A TCOF1 MAP4 MYO9B WDR12 HADHB AFF4	4.17e-05	182	103	7	int:GRK5
Interaction	DHX40 interactions	TFIP11 NKRF TASOR2 ZNF106 ZNF638 PDCD11 FUS RAI1	4.20e-05	249	103	8	int:DHX40
Interaction	HDAC1 interactions	MYBBP1A RPAP3 TAF1B GON4L KIF4A CHD8 PARP1 SINHCAF MORF4L2 CHFR ZNF638 KMT2A AFF1 TGIF2LX TOP2A RAI1 VCPIP1	4.41e-05	1108	103	17	int:HDAC1
Interaction	BRD3 interactions	MYO9B CHD8 NSD3 LIG3 PARP1 FAU RPL7L1 KMT2A TAF4B TOP2A RAI1	4.50e-05	494	103	11	int:BRD3
Interaction	RPL28 interactions	CYLD MYBBP1A TCOF1 MAP4 TAF1B KAT6A RPL7L1 PDCD11 ZNF770 WDR12 TOP2A	4.50e-05	494	103	11	int:RPL28
Interaction	FGFBP1 interactions	MYBBP1A NKRF RPL7L1 ZNF638 PDCD11 KMT2A FGF7 ZNF770	5.25e-05	257	103	8	int:FGFBP1
Interaction	SRPK3 interactions	MYBBP1A TFIP11 NKRF RPL7L1 ZNF638 PDCD11 TOP2A	5.48e-05	190	103	7	int:SRPK3
Interaction	USP36 interactions	MYBBP1A POLR1A NKRF PARP1 FAU RPL7L1 SHPRH ZNF638 PDCD11 WDR12 HADHB TOP2A	5.54e-05	599	103	12	int:USP36
Interaction	DDRGK1 interactions	EPRS1 MYBBP1A POLR1A TCOF1 PRPF38B TFIP11 NKRF PARP1 FAU RPL7L1 SHPRH PDCD11 WDR12 EXOC1 HADHB FUS CPSF3 TOP2A	5.78e-05	1249	103	18	int:DDRGK1
Interaction	KAT6A interactions	POLR1A KAT6A NKRF FAU RPL7L1 MORF4L2 GLUD1 SHPRH KMT2A TOP2A AFF4	5.99e-05	510	103	11	int:KAT6A
Interaction	RBM4B interactions	MYBBP1A KAT6A NKRF RPL7L1 ZNF638 PDCD11 ZNF770 TOP2A	6.01e-05	262	103	8	int:RBM4B
Interaction	RPL23A interactions	CYLD EPRS1 MYBBP1A KAT6A TFIP11 NKRF FAU RPL7L1 PDCD11 KMT2A ZNF770 RAI1	6.20e-05	606	103	12	int:RPL23A
Interaction	XRCC6 interactions	MYBBP1A MAP4 RPAP3 KIF4A TFIP11 CHD8 DYSF LIG3 PARP1 CFDP1 ZNF638 KMT2A FUS TOP2A AFF4	7.30e-05	928	103	15	int:XRCC6
Interaction	ZC3H10 interactions	MYBBP1A TAF1B NKRF RPL7L1 ZNF638 PDCD11 ZNF770	7.57e-05	200	103	7	int:ZC3H10
Interaction	NEIL1 interactions	MYBBP1A NKRF LIG3 RPL7L1 ZNF638 PDCD11 ZNF770 WDR12	8.64e-05	276	103	8	int:NEIL1
Interaction	HNRNPC interactions	CYLD EPRS1 MYBBP1A TCOF1 MAP4 TFIP11 NKRF CRNKL1 LARP4B FUS CAMSAP2 TOP2A	9.51e-05	634	103	12	int:HNRNPC
Interaction	MIR92A2 interactions	EPRS1 EDC4 PDCD11 FUS CPSF3	9.85e-05	90	103	5	int:MIR92A2
Interaction	TNFRSF1B interactions	MYBBP1A MIS18BP1 DNAH14 LIG3 ZNF770 TOP2A	1.05e-04	146	103	6	int:TNFRSF1B
Interaction	RPA4 interactions	TCOF1 MAP4 EDC4 WASHC2A PGD LIG3 PARP1 ZNF638 HADHB TOP2A	1.07e-04	452	103	10	int:RPA4
Interaction	SUZ12 interactions	EPRS1 MYBBP1A CHD8 NKRF TASOR2 LIG3 CRNKL1 PARP1 SHPRH ZNF638 PDCD11 FUS	1.10e-04	644	103	12	int:SUZ12
Interaction	CDC5L interactions	CYLD TTF2 NRG1 MYBBP1A KIF4A CHD8 EDC4 CRNKL1 PARP1 ZNF638 EXOC1 FUS CPSF3 TOP2A	1.13e-04	855	103	14	int:CDC5L
Interaction	CBX3 interactions	MIS18BP1 TCOF1 KIF4A CHD8 SUV39H2 PGD NSD3 LIG3 PARP1 CFDP1 KMT2A TOP2A	1.13e-04	646	103	12	int:CBX3
Interaction	ZNF48 interactions	MYBBP1A TAF1B RPL7L1 MORF4L2 PDCD11 ZNF770	1.17e-04	149	103	6	int:ZNF48
Interaction	PIP4K2A interactions	TCOF1 PRPF38B CHD8 EDC4 GLUD1 AFF1 AFF4	1.22e-04	216	103	7	int:PIP4K2A
Interaction	CHD3 interactions	EPRS1 MYBBP1A KAT6A TFIP11 NKRF LIG3 PARP1 SHPRH PDCD11 KMT2A FUS TOP2A RAI1	1.27e-04	757	103	13	int:CHD3
Interaction	RNF2 interactions	EPRS1 MYBBP1A POLR1A DYSF CRNKL1 PARP1 SINHCAF RPL7L1 GLUD2 ZNF638 PDCD11 KMT2A WDR12 TOP2A	1.30e-04	866	103	14	int:RNF2
Interaction	RPL4 interactions	CYLD MYBBP1A TAF1B KAT6A NKRF RPL7L1 GLUD1 ZNF638 PDCD11 ZNF770 WDR12 FUS TOP2A	1.39e-04	764	103	13	int:RPL4
Interaction	TNIP1 interactions	EPRS1 TTF2 MYBBP1A POLR1A TCOF1 MAP4 NKRF LIG3 CRNKL1 PARP1 RPL7L1 MORF4L2 PDCD11 EXOC1 FUS CPSF3 TOP2A	1.39e-04	1217	103	17	int:TNIP1
Interaction	MIR21 interactions	EPRS1 EDC4 ZNF106 PDCD11 FUS	1.40e-04	97	103	5	int:MIR21
Interaction	SIN3A interactions	GON4L KIF4A PARP1 SINHCAF MORF4L2 CHFR SHPRH KMT2A TGIF2LX	1.45e-04	380	103	9	int:SIN3A
Interaction	PHF14 interactions	KAT6A GON4L PARP1 CFDP1 RAI1	1.62e-04	100	103	5	int:PHF14
Interaction	ACADVL interactions	TAF1B DENR PARP1 SINHCAF ETAA1 HADHB	1.67e-04	159	103	6	int:ACADVL
Interaction	NLE1 interactions	MYBBP1A MIS18BP1 TCOF1 ZNF532 PDCD11 WDR12 TOP2A	1.71e-04	228	103	7	int:NLE1
Interaction	RPL31 interactions	CYLD MYBBP1A TCOF1 KAT6A NKRF NSD3 LIG3 ZNF106 RPL7L1 PDCD11 ZNF770 TOP2A	1.83e-04	680	103	12	int:RPL31
Interaction	RELA interactions	MYBBP1A POLR1A NKRF PARP1 PTPRJ CHFR PDCD11 AFF1 FUS TAF4B	1.90e-04	485	103	10	int:RELA
Interaction	SUMO2 interactions	EPRS1 WASHC2C MAP4 KIF4A CHD8 EDC4 PGD PARP1 LARP4B ZNF638 TOP2A	2.19e-04	591	103	11	int:SUMO2
Interaction	DGCR8 interactions	MYBBP1A NKRF PARP1 RPL7L1 ZNF770 WDR12 FUS	2.46e-04	242	103	7	int:DGCR8
Interaction	SRSF6 interactions	CYLD MYBBP1A PRPF38B NKRF CRNKL1 RPL7L1 ZNF638 PDCD11 KMT2A FUS	2.54e-04	503	103	10	int:SRSF6
Interaction	RPL36 interactions	CYLD MYBBP1A TAF1B KAT6A RPL7L1 PDCD11 KMT2A ZNF770 WDR12 TOP2A	2.58e-04	504	103	10	int:RPL36
Interaction	NOC3L interactions	MYBBP1A TCOF1 PARP1 FAU RPL7L1 PDCD11 WDR12	2.58e-04	244	103	7	int:NOC3L
Interaction	RCHY1 interactions	MYBBP1A CHD8 NKRF PARP1 TGIF2LX HADHB FUS TOP2A	2.64e-04	325	103	8	int:RCHY1
Interaction	PRMT1 interactions	CYLD EPRS1 ARHGAP32 MYBBP1A MAP4 PGD NKRF TASOR2 CRNKL1 PARP1 LARP4B WDR12 HADHB FUS	2.68e-04	929	103	14	int:PRMT1
Interaction	PML interactions	MYBBP1A WASHC2C MAP4 RPAP3 KAT6A CHD8 LIG3 ZNF106 PARP1 CHFR SHPRH KMT2A HADHB TOP2A	2.80e-04	933	103	14	int:PML
Interaction	CAPZB interactions	CYLD EPRS1 POLR1A WASHC2C RPAP3 EDC4 WASHC2A CRNKL1 PARP1 LARP4B FAU GLUD1 HADHB TOP2A RAI1	2.80e-04	1049	103	15	int:CAPZB
Interaction	IFI16 interactions	MYBBP1A EDC4 NKRF LIG3 CRNKL1 PARP1 LARP4B MORF4L2 ZNF638 PDCD11 WDR12 TOP2A	2.86e-04	714	103	12	int:IFI16
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF2 AFF1 AFF4	2.22e-07	4	70	3	1145
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF2 AFF1 AFF4	4.59e-06	9	70	3	1280
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	LIG3 PARP1	1.48e-05	2	70	2	94
GeneFamily	WASH complex	WASHC2C WASHC2A	2.19e-04	6	70	2	1331
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SUV39H2 NSD3 KMT2A	3.05e-04	34	70	3	487
GeneFamily	PHD finger proteins	KAT6A NSD3 SHPRH KMT2A	4.10e-04	90	70	4	88
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	LIG3 PARP1	1.50e-03	15	70	2	26
GeneFamily	Zinc fingers C2HC-type\|PHD finger proteins\|Lysine acetyltransferases	KAT6A ZC2HC1B	1.71e-03	16	70	2	66
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRJ PTPRO	2.96e-03	21	70	2	813
GeneFamily	G-patch domain containing\|Minor histocompatibility antigens	TFIP11 NKRF	3.25e-03	22	70	2	579
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RAB11FIP2 C2CD4C	8.55e-03	36	70	2	823
Coexpression	GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN	TRPM6 TAGAP SFMBT2 TXK EML5 TAF4B CAMSAP2	7.03e-06	179	103	7	M6689
Coexpression	AFFAR_YY1_TARGETS_DN	GATB SUV39H2 LIG3 PTPRO FGF7 FUS GREM1 TOP2A	8.88e-06	260	103	8	M1471
Coexpression	LEE_BMP2_TARGETS_DN	TTF2 MYBBP1A POLR1A TCOF1 SUV39H2 PGD NKRF PARP1 SINHCAF RPL7L1 PDCD11 FGF7 WDR12 TAF4B	1.21e-05	904	103	14	M2325
Coexpression	GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN	KAT6A R3HCC1 PRPF38B VPS13D FAU FUS CXCL11	1.36e-05	198	103	7	M5507
Coexpression	LEE_BMP2_TARGETS_DN	TTF2 MYBBP1A POLR1A TCOF1 SUV39H2 PGD NKRF PARP1 SINHCAF RPL7L1 PDCD11 FGF7 WDR12 TAF4B	1.51e-05	922	103	14	MM1068
Coexpression	AFFAR_YY1_TARGETS_DN	GATB SUV39H2 LIG3 PTPRO FGF7 FUS GREM1 TOP2A	1.64e-05	283	103	8	MM1157
Coexpression	SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	TTF2 TCOF1 MAP4 GATB PARP1 FAU MORF4L2 GLUD1 CFDP1 TOP2A	2.14e-05	484	103	10	M14665
Coexpression	GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN	CYLD LDLRAP1 TCOF1 TAGAP TASOR2 EML5	6.80e-05	175	103	6	M2940
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	CYLD MIS18BP1 MAP4 RAB11FIP2 GATA6 CHD8 NSD3 TASOR2 CREBRF EML5 SHPRH FUS TAF4B VCPIP1	1.82e-05	776	101	14	gudmap_developingGonad_e14.5_ ovary_1000
ToppCell	CV-Mild-3\|Mild / Virus stimulation, Condition and Cluster	TCOF1 GATB DYSF SUV39H2 TTLL7 TOP2A	2.59e-06	166	104	6	5599f90fc0e15a3670b03187085eba91228390a2
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5\|Striatum / BrainAtlas - Mouse McCarroll V32	TTF2 MIS18BP1 KIF4A SINHCAF FUS TOP2A	4.55e-06	183	104	6	f20b0d71f857ac35868fd80531050ad8b6091716
ToppCell	PBMC-Mild-cDC_9\|Mild / Compartment, Disease Groups and Clusters	UNC13B POLR1A P2RY12 TTLL7 LARP4B TOP2A	4.69e-06	184	104	6	2e0c9a2c40c892a2d435eafb31f1f838de9baf15
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYT17 RAB11FIP2 FREM1 PTPRJ MYO3B AFF1	5.81e-06	191	104	6	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	facs-Skin-Telogen-3m-Epithelial\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RY12 MORF4L2 GLUD1 AFF1 HADHB AFF4	6.35e-06	194	104	6	4d7fc4d0a55abb3b645116d13a983bbedc55f70c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYT17 RAB11FIP2 FREM1 PTPRJ MYO3B AFF1	6.35e-06	194	104	6	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	facs-Skin-Telogen-3m\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RY12 MORF4L2 GLUD1 AFF1 HADHB AFF4	6.35e-06	194	104	6	ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b
ToppCell	facs-Skin-Telogen\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RY12 MORF4L2 GLUD1 AFF1 HADHB AFF4	6.35e-06	194	104	6	bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6
ToppCell	Severe-B_naive-1\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	WASHC2C KAT6A WASHC2A NSD3 SINHCAF	3.59e-05	159	104	5	2881b054bbeb479221ee3c38bbd9b0815b123579
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	P2RY12 TAGAP PTPRJ PTPRO GLUD1	3.81e-05	161	104	5	8937f6b92cb2a93ea8c4780d9200a518c3112e53
ToppCell	5'-Adult-LymphNode-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AFF2 P2RY12 SYT17 PARP1 ZNF532	3.81e-05	161	104	5	d8140e7772b4e327dafa3536881a784d3c328d2a
ToppCell	PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIS18BP1 MYO9B KIF4A SINHCAF TOP2A	5.22e-05	172	104	5	1171e754fd503a0c1152162fcc12a115088a08c7
ToppCell	P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TTF2 KIF4A TASOR2 ETAA1 TOP2A	5.22e-05	172	104	5	7c238a7375341d4647ba7274d93fddfb6fae7ce4
ToppCell	343B-Fibroblasts-Fibroblast-H-\|343B / Donor, Lineage, Cell class and subclass (all cells)	IQCH NKRF FREM1 FGF7 CXCL11	5.51e-05	174	104	5	2627c3983009839fedbc5e3f628739dc026447f4
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_2\|343B / Donor, Lineage, Cell class and subclass (all cells)	NRG1 MEIKIN KIF4A LCT TOP2A	5.51e-05	174	104	5	a75ba49ccea6bd3d78ada1092b46deb5202c58a5
ToppCell	343B-Fibroblasts-Fibroblast-H\|343B / Donor, Lineage, Cell class and subclass (all cells)	IQCH NKRF FREM1 FGF7 CXCL11	5.51e-05	174	104	5	507a33e58f62e2b72f0bcc743e84dbd0bf705a15
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AFF2 MEIKIN GATA6 GLUD1 FGGY	6.30e-05	179	104	5	7c8a2fa1326c73dc9e774df645b572864fd97133
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MIS18BP1 KIF4A SINHCAF FUS TOP2A	6.47e-05	180	104	5	44988c34861df359a68376500c42a64fbcc4b431
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POLR1A PTPRJ ZNF770 ELAC1 CAMSAP2	6.47e-05	180	104	5	be10fe5bf7c3a671c42704ce7dd8226ab6896794
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POLR1A PTPRJ ZNF770 ELAC1 CAMSAP2	6.47e-05	180	104	5	3b747a517ce75ef2ff09011c037dad7b01ed3e03
ToppCell	droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYBBP1A TCOF1 PARP1 SINHCAF PDCD11	7.00e-05	183	104	5	92ef926e6c1de8477fa4f35d1dae85482d8009de
ToppCell	droplet-Marrow-nan-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYBBP1A TCOF1 PARP1 SINHCAF PDCD11	7.00e-05	183	104	5	24db9cc717e651586317c6a8e03a3401651273c1
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TTF2 MIS18BP1 KIF4A GLUD2 TOP2A	7.00e-05	183	104	5	29b62dd542bc3f8df843998f577724f3818d4271
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIS18BP1 TCOF1 KIF4A PARP1 TOP2A	7.18e-05	184	104	5	8f40093de5bb978f046d66e8f05f333686a009a4
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	EPRS1 TTF2 RAB11FIP2 SHPRH FUS	7.37e-05	185	104	5	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCOF1 KAT6A ZNF106 PARP1 ZNF638	7.37e-05	185	104	5	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RY12 MAP4 AFF1 CAMSAP2 AFF4	7.37e-05	185	104	5	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	EPRS1 TTF2 RAB11FIP2 SHPRH FUS	7.56e-05	186	104	5	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-Cd4_positive_Macrophages\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYBBP1A TCOF1 PARP1 PDCD11 WDR12	8.56e-05	191	104	5	45023854f285ac465f23ea1b33c970e14992e709
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYBBP1A TCOF1 PARP1 PDCD11 WDR12	8.56e-05	191	104	5	6890a8e4b4530987a5b044614fcd7e00716a4d66
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	TCOF1 PRPF38B PDCD11 KMT2A TOP2A	8.77e-05	192	104	5	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RAB11FIP2 FREM1 PTPRJ MYO3B AFF1	9.21e-05	194	104	5	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	Control-B_naive-2\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TCOF1 TAGAP NSD3 CREBRF FAU	9.44e-05	195	104	5	50b1795eb37551777db13b8e9d2df1ef020bfa13
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	WASHC2C DYSF WASHC2A PGD NSD3	9.67e-05	196	104	5	15397ec27167bb2fb6fec120b68bf38fc71b2670
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_3\|COVID-19_Mild / Disease condition and Cell class	WASHC2C DYSF WASHC2A PGD NSD3	9.67e-05	196	104	5	f245e929a286cb097130572e1027b4f01be8b04d
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P2RY12 MAP4 MORF4L2 GLUD1 AFF4	9.67e-05	196	104	5	151f1a29a91f8b234e9b6ed062666357a2f69128
Drug	Norethynodrel [68-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A	MAP4 SYT17 TFIP11 LCT DYSF LIG3 ETAA1 AFF1 VCPIP1	3.20e-07	198	104	9	7471_UP
Drug	isosteviol lactone	LCT GLUD1 GLUD2	9.20e-07	5	104	3	CID000401559
Drug	e511	GATA6 PGD GLUD1 GLUD2	1.88e-06	20	104	4	CID000024644
Drug	AC1L1GWH	LCT GLUD1 GLUD2	7.62e-06	9	104	3	CID000003872
Drug	phenyltriethoxysilane	GLUD1 GLUD2	2.07e-05	2	104	2	CID000013075
Drug	G-3SH	GLUD1 GLUD2	2.07e-05	2	104	2	CID000174237
Drug	iodoacetyldiethylstilbestrol	GLUD1 GLUD2	2.07e-05	2	104	2	CID006455327
Drug	methylmercuric bromide	GLUD1 GLUD2	2.07e-05	2	104	2	CID000068175
Drug	5-methylisophthalate	GLUD1 GLUD2	2.07e-05	2	104	2	CID000068137
Drug	x 1 s	GLUD1 GLUD2	2.07e-05	2	104	2	CID000409694
Drug	dimethylthioarsinic acid	NRG1 AFF1 AFF4	2.56e-05	13	104	3	ctd:C547156
Drug	Pandurol	PGD GLUD1 GLUD2	2.56e-05	13	104	3	CID000019618
Drug	AC1Q6SXM	AFF2 LCT NKRF GLUD1 GLUD2	3.11e-05	79	104	5	CID000000717
Drug	Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; MCF7; HT_HG-U133A	ARHGAP32 CHD8 LIG3 LARP4B KMT2A FUS FGGY	3.41e-05	197	104	7	5292_DN
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; PC3; HT_HG-U133A	MYBBP1A MAP4 MYO9B RAB11FIP2 DYSF TTLL7 VPS13D	3.64e-05	199	104	7	6361_DN
Drug	2-methyleneglutarate	PGD GLUD1 GLUD2	4.97e-05	16	104	3	CID000095155
Drug	geldanamycin	EPRS1 MIS18BP1 KAT6A PARP1 ZNF638 KMT2A FGF7 ZNF770 AFF4	5.18e-05	371	104	9	ctd:C001277
Drug	lenthionine	GLUD1 GLUD2	6.18e-05	3	104	2	CID000067521
Drug	mildiomycin	GLUD1 GLUD2	6.18e-05	3	104	2	CID000125665
Drug	methoxyethylmercury	GLUD1 GLUD2	6.18e-05	3	104	2	CID000115155
Drug	4-methylumbelliferyl laurate	GLUD1 GLUD2	6.18e-05	3	104	2	CID000600674
Drug	methylmercuric iodide	GLUD1 GLUD2	6.18e-05	3	104	2	CID000067347
Drug	silicon;titanium	ARHGAP32 FGF7	6.18e-05	3	104	2	CID006336553
Drug	deoxynivalenol	MYBBP1A WASHC2C TCOF1 MAP4 SUV39H2 PARP1 PTPRJ PDCD11 KMT2A CXCL11	7.15e-05	481	104	10	ctd:C007262
Drug	2 pc	NRG1 GLUD1 GLUD2	7.19e-05	18	104	3	CID000440046
Drug	methyl benzoquate	GLUD1 GLUD2	1.23e-04	4	104	2	CID000026383
Drug	pentenoic acid	GLUD1 GLUD2	1.23e-04	4	104	2	CID000012299
Drug	alpha-ketoglutaramate	GLUD1 GLUD2	1.23e-04	4	104	2	CID000000048
Drug	ureidoglycine	GLUD1 GLUD2	1.23e-04	4	104	2	CID000439649
Drug	Ivin	GLUD1 GLUD2	1.23e-04	4	104	2	CID000014083
Drug	8-BDB-TADP	GLUD1 GLUD2	1.23e-04	4	104	2	CID000130791
Drug	cadina-3,9-diene	GLUD1 GLUD2	1.23e-04	4	104	2	CID000010657
Drug	AC1L9CUQ	GLUD1 GLUD2	1.23e-04	4	104	2	CID000442451
Drug	luxabendazole	GLUD1 GLUD2	1.23e-04	4	104	2	CID000072019
Drug	N-butylmaleimide	GLUD1 GLUD2	1.23e-04	4	104	2	CID000239780
Drug	alpha-methylglutamate	GLUD1 GLUD2	1.23e-04	4	104	2	CID000095440
Drug	2b E2	GLUD1 GLUD2	1.23e-04	4	104	2	CID005327076
Drug	resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	TCOF1 MAP4 PRPF38B NKRF LIG3 TOP2A	1.59e-04	176	104	6	958_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; HL60; HT_HG-U133A	TCOF1 MAP4 LIG3 PDCD11 WDR12 TAF4B	1.69e-04	178	104	6	2977_DN
Drug	deoxynivalenol	PTPRJ GLUD1 GLUD2 FUS	1.99e-04	63	104	4	CID000040024
Drug	bathocuproine	GLUD1 GLUD2	2.05e-04	5	104	2	CID000065149
Drug	AC1NRA4I	GLUD1 GLUD2	2.05e-04	5	104	2	CID005287695
Drug	1-pheg	GLUD1 GLUD2	2.05e-04	5	104	2	CID000152041
Drug	5'-FSBAzA	GLUD1 GLUD2	2.05e-04	5	104	2	CID000130430
Drug	adenine N1-oxide	GLUD1 GLUD2	2.05e-04	5	104	2	CID000093557
Drug	choline sulfate	GLUD1 GLUD2	2.05e-04	5	104	2	CID000000485
Drug	l-413	GLUD1 GLUD2	2.05e-04	5	104	2	CID000012475
Drug	3-aminopicolinate	GLUD1 GLUD2	2.05e-04	5	104	2	CID000073836
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	MAP4 CHD8 SUV39H2 LARP4B AFF1 CAMSAP2	2.21e-04	187	104	6	4989_DN
Drug	MEGX	MORF4L2 GLUD1 GLUD2	2.23e-04	26	104	3	CID000024415
Drug	AC1O54Y4	EPRS1 PGD GLUD1 GLUD2	2.25e-04	65	104	4	CID006452212
Drug	Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; HL60; HG-U133A	TCOF1 MAP4 TFIP11 TASOR2 VPS13D TAF4B	2.27e-04	188	104	6	1622_DN
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A	EPRS1 MIS18BP1 MAP4 KAT6A KMT2A FUS	2.27e-04	188	104	6	4545_DN
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	EPRS1 MIS18BP1 MAP4 TFIP11 KMT2A VCPIP1	2.47e-04	191	104	6	6020_DN
Drug	L-Glutamic Acid	EPRS1 GATB GLUD1 GLUD2	2.67e-04	68	104	4	DB00142
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	CYLD LDLRAP1 MYO9B SYT17 LIG3 VPS13D	2.76e-04	195	104	6	4533_DN
Drug	Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A	ARHGAP32 MAP4 ZNF106 PDCD11 FUS CAMSAP2	2.76e-04	195	104	6	6234_DN
Drug	Betulinic acid [472-15-1]; Up 200; 8.8uM; HL60; HT_HG-U133A	TCOF1 MAP4 GON4L EDC4 LIG3 PDCD11	2.76e-04	195	104	6	1345_UP
Drug	ANIT	LCT GLUD1 GLUD2 CXCL11	2.83e-04	69	104	4	CID000011080
Drug	nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A	ARHGAP32 MYBBP1A MAP4 TAF1B LIG3 FGGY	2.84e-04	196	104	6	1164_DN
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A	LDLRAP1 TTF2 GON4L TFIP11 VPS13D FGGY	2.84e-04	196	104	6	1695_DN
Drug	Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HG-U133A	CYLD ARHGAP32 ZNF106 VPS13D CFDP1 EXOC1	2.84e-04	196	104	6	1961_UP
Drug	Dydrogesterone [152-62-5]; Up 200; 12.8uM; HL60; HT_HG-U133A	ARHGAP32 MAP4 MYO9B TTLL7 VPS13D CAMSAP2	2.92e-04	197	104	6	2156_UP
Drug	Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A	MYBBP1A MAP4 EDC4 DYSF LIG3 LARP4B	2.92e-04	197	104	6	2641_DN
Drug	Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A	CYLD VPS13D PTPRO KMT2A AFF1 FUS	2.92e-04	197	104	6	3832_UP
Drug	Paclitaxel [33069-62-4]; Down 200; 4.6uM; MCF7; HT_HG-U133A	MAP4 MYO9B PRPF38B TFIP11 LIG3 LARP4B	2.92e-04	197	104	6	5320_DN
Drug	Tamoxifen citrate [54965-24-1]; Down 200; 7uM; MCF7; HT_HG-U133A	MYO9B TFIP11 SUV39H2 LIG3 ETAA1 VCPIP1	2.92e-04	197	104	6	6768_DN
Drug	Tranexamic acid [1197-18-8]; Up 200; 25.4uM; HL60; HG-U133A	MIS18BP1 MAP4 TASOR2 LIG3 VPS13D PDCD11	2.92e-04	197	104	6	1401_UP
Drug	Methantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A	MYO9B RAB11FIP2 GATB GON4L TFIP11 VCPIP1	3.00e-04	198	104	6	3560_DN
Drug	AG-028671 [847803-03-6]; Down 200; 10uM; MCF7; HT_HG-U133A	MYBBP1A MYO9B NKRF NSD3 LARP4B VCPIP1	3.00e-04	198	104	6	6587_DN
Drug	Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; HL60; HT_HG-U133A	TCOF1 MYO9B KAT6A PTPRO KMT2A VCPIP1	3.00e-04	198	104	6	1330_UP
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; HL60; HT_HG-U133A	MAP4 GON4L TFIP11 LIG3 VPS13D CAMSAP2	3.00e-04	198	104	6	1320_UP
Drug	Roxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A	LDLRAP1 ARHGAP32 MAP4 LARP4B ETAA1 VCPIP1	3.00e-04	198	104	6	5470_DN
Drug	alpha-monofluoromethylputrescine	GLUD1 GLUD2	3.06e-04	6	104	2	CID000134201
Drug	dimethylmalonate	GLUD1 GLUD2	3.06e-04	6	104	2	CID000007943
Drug	2-methyl-1,2,3,4-tetrahydroisoquinoline	GLUD1 GLUD2	3.06e-04	6	104	2	CID000015362
Drug	lanosol	GLUD1 GLUD2	3.06e-04	6	104	2	CID000078659
Drug	dadAB	GLUD1 GLUD2	3.06e-04	6	104	2	CID000022626
Drug	N-methylhydantoin	GLUD1 GLUD2	3.06e-04	6	104	2	CID000069217
Drug	diazonium-1-H-tetrazole	GLUD1 GLUD2	3.06e-04	6	104	2	CID000188312
Drug	AC1L448Y	GLUD1 GLUD2	3.06e-04	6	104	2	CID000200389
Drug	2-BDB-TAMP	GLUD1 GLUD2	3.06e-04	6	104	2	CID000127220
Drug	Emid	GLUD1 GLUD2	3.06e-04	6	104	2	CID000074798
Drug	AC1L8SA5	GLUD1 GLUD2	3.06e-04	6	104	2	CID000407285
Drug	isodiazinon	GLUD1 GLUD2	3.06e-04	6	104	2	CID000133913
Drug	Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	CYLD AFF2 RAB11FIP2 LIG3 VPS13D KMT2A	3.08e-04	199	104	6	4741_DN
Drug	Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; HL60; HT_HG-U133A	ARHGAP32 MAP4 LCT TXK AFF1 CAMSAP2	3.08e-04	199	104	6	2449_UP
Drug	Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A	MAP4 MYO9B SYT17 RAB11FIP2 KAT6A ETAA1	3.17e-04	200	104	6	7336_DN
Disease	fascioliasis (biomarker_via_orthology)	GLUD1 GLUD2	3.40e-05	3	100	2	DOID:885 (biomarker_via_orthology)
Disease	childhood absence epilepsy (biomarker_via_orthology)	GLUD1 GLUD2	1.69e-04	6	100	2	DOID:1825 (biomarker_via_orthology)
Disease	type 2 diabetes mellitus (implicated_via_orthology)	AFF2 PARP1 AFF1 AFF4	4.57e-04	105	100	4	DOID:9352 (implicated_via_orthology)
Disease	Facies	CHD8 AFF4	5.03e-04	10	100	2	C0282631
Disease	Macrocephaly	CHD8 BRWD3	6.13e-04	11	100	2	C0221355
Disease	acute myeloid leukemia (implicated_via_orthology)	KMT2A TOP2A	7.34e-04	12	100	2	DOID:9119 (implicated_via_orthology)
Disease	red blood cell density measurement	NRG1 RERG POLR1A WASHC2C RAB11FIP2 ZNF106 LARP4B GLUD1 AFF1 TAF4B	8.14e-04	880	100	10	EFO_0007978
Disease	Malignant neoplasm of breast	NRG1 DYSF SUV39H2 PARP1 ZNF532 HEATR9 AFF1 HADHB FUS CPSF3 TOP2A	1.04e-03	1074	100	11	C0006142
Disease	hepatic encephalopathy (biomarker_via_orthology)	GLUD1 GLUD2	1.16e-03	15	100	2	DOID:13413 (biomarker_via_orthology)
Disease	Mental Retardation, Psychosocial	GON4L CHD8 PARP1 RAI1	1.30e-03	139	100	4	C0025363
Disease	Profound Mental Retardation	GON4L CHD8 PARP1 RAI1	1.30e-03	139	100	4	C0020796
Disease	Mental deficiency	GON4L CHD8 PARP1 RAI1	1.30e-03	139	100	4	C0917816
Disease	migraine disorder	SUV39H2 ZNF106 LARP4B MYO3B CFDP1 WDR12	1.38e-03	357	100	6	MONDO_0005277
Disease	platelet-to-lymphocyte ratio	P2RY12 RPAP3 PGD PTPRJ AFF1 RAI1	1.50e-03	363	100	6	EFO_0008446
Disease	interleukin-2 receptor subunit alpha measurement	PRPF38B TASOR2	2.29e-03	21	100	2	EFO_0010587
Disease	Congenital diaphragmatic hernia	GATA6 FREM1	2.29e-03	21	100	2	C0235833
Disease	Precursor B-cell lymphoblastic leukemia	KMT2A AFF1	2.29e-03	21	100	2	C1292769
Disease	response to clopidogrel, cardiovascular event measurement	DYSF FREM1	2.75e-03	23	100	2	EFO_0006919, GO_1903493
Disease	Alveolitis, Fibrosing	PARP1 FGF7 GREM1	2.85e-03	83	100	3	C4721507
Disease	congenital diaphragmatic hernia (biomarker_via_orthology)	GATA6 FREM1	2.99e-03	24	100	2	DOID:3827 (biomarker_via_orthology)
Disease	Pulmonary Fibrosis	PARP1 FGF7 GREM1	3.05e-03	85	100	3	C0034069

Protein segments in the cluster

Peptide	Gene	Start	Entry
KTKGKSKLNTITPVV	CHD8	526	Q9HCK8
SKLNTITPVVGKKRK	CHD8	531	Q9HCK8
PKIRKGAVQKVSKKL	CPSF3	591	Q9UKF6
KKAKVKINPVQQSRP	CREBRF	236	Q8IUR6
VSQRTIGKKQPKKVE	AFF2	621	P51816
PVTNVKKGKIAKNSI	EPHA5	471	P54756
ERIQASKKLKGPQKF	PGD	296	P52209
PKQTRKKKGGLVSIA	BRWD3	901	Q6RI45
AGKKQSQVIPKTVRI	GATB	171	O75879
VQELPKTITGKIKRN	ACSM4	556	P0C7M7
VPGKLQKQRSTIVKN	C2CD4C	351	Q8TF44
KTKKTLAKPNIRNVV	HADHB	41	P55084
NAPKKEKSVLQGKLT	ATP2B3	351	Q16720
TTQRRTVGKKQPKKA	AFF4	556	Q9UHB7
VLKIRPLTQGTKQSK	R3HCC1	376	Q9Y3T6
KAAVPQKKGVKNLVS	RAI1	456	Q7Z5J4
SRLIKVISKPSQKKQ	RBPJL	186	Q9UBG7
KARGSNKVKIQPVAK	EDC4	111	Q6P2E9
PRAKIKVSKLIKGSN	IQCH	126	Q86VS3
AVKKLTVNPGTKSKL	PARP1	651	P09874
IKIQKKPGKSELRIN	NRG1	86	Q02297
KTILKIPSAQQRKKA	OR6C65	221	A6NJZ3
SGKKLQKVTLKVSPR	LDLRAP1	81	Q5SW96
SQIKPKKSKLIRVEN	PTPRJ	1011	Q12913
KQTIKITAKVGTLKR	MIS18BP1	956	Q6P0N0
KQPAGKVQIVSKKVS	MAP4	986	P27816
LQPPTKKKRVTRVKQ	GREM1	161	O60565
KQIGIIKTNKKTGQP	FUS	306	P35637
KRTPQSDLKGKIKGQ	LRRC53	701	A6NM62
VKTFQGKPIKARIKA	LARP4B	296	Q92615
KRKAKVSIISQPQKT	FREM1	1966	Q5H8C1
RQKLSKLQTIEPKVK	LCT	261	P09848
SVRKTRKNKQKTPGN	MORF4L2	71	Q15014
PGTRQVKNKGVIVKK	MEIKIN	341	A0A087WXM9
VGKVPRKKVNVKVFI	P2RY12	226	Q9H244
TPKKKAVVQAKLTTT	LIG3	191	P49916
KSRPTKQKLKQRGIL	ARHGAP32	351	A7KAX9
AQQKVPSKLKKLVGS	MYBBP1A	221	Q9BQG0
SPLTKQLGKGRKKQI	ETAA1	111	Q9NY74
TKKPIKGNTKISVAN	ETAA1	251	Q9NY74
KNGLKKRKLTNPVQL	PTPRO	906	Q16827
GRPKNRLKKQNTVSK	KAT6A	336	Q92794
EGIQTRKRKPKNINK	GATA6	486	Q92908
KLKVVKKQTCPLQTG	CHFR	86	Q96EP1
QKTQGKKRKAQSIPA	CFDP1	46	Q9UEE9
TAAGKQRIPKVAKVK	CRNKL1	166	Q9BZJ0
SKVGKVVFPRLQDKK	FGGY	511	Q96C11
KQLTKSNAPRVKAKI	GLUD1	386	P00367
PTASKNKRKKEIGVQ	GON4L	1821	Q3T8J9
GSSKIAIQKITLKKP	DNAH14	281	Q0VDD8
RGQIKQKKKTVPQKV	DENR	101	O43583
KPTKLVKVSRKNIQG	KIF4A	1071	O95239
QATKIKKLRAGKLSP	KMT2A	266	Q03164
RPVQVKVVKVKKSDK	EXOC1	46	Q9NV70
EKLQTNNVGKKKRPI	EML5	1346	Q05BV3
TDKQTQKLLKVPKGS	CYLD	31	Q9NQC7
ALNQKGIPVRGKKTK	FGF7	166	P21781
GIPVRGKKTKKEQKT	FGF7	171	P21781
VKKRTKVIKNSVNPV	DYSF	31	O75923
PQVVKQKKQRPKSIH	CAMSAP2	1256	Q08AD1
NPKSKQARLIIKKVE	CXCL11	76	O14625
KQLTKSNAPRVKAKI	GLUD2	386	P49448
KKVAVTPVKKLAQIG	TAF4B	171	Q92750
QGPKKQTRLGLEAKK	EPRS1	1006	P07814
QKLTGIAQPKKKVKV	TGIF2LX	181	Q8IUE1
VPVLNTKKALKRVKS	POLR1A	1266	O95602
LPDQKNSKQTGVKRK	SYT17	236	Q9BSW7
NSKQTGVKRKTQKPV	SYT17	241	Q9BSW7
QGKTKRPVDLKIKNL	TAGAP	431	Q8N103
SVQAKGTNKLRKPKL	TCOF1	1116	Q13428
LKKTQPTVINNLKKG	NKRF	511	O15226
ILKRGQAKVKNKTIP	RPL7L1	161	Q6DKI1
PNTQIKALNRGLKKK	TAF1B	51	Q53T94
DKTKKQAVGSPRKIQ	SHPRH	521	Q149N8
LRKKLVPSTKKGKSQ	SHPRH	576	Q149N8
KKPKNVTLILVGNKA	RERG	106	Q96A58
QRQTVGTKQPKKPVK	AFF1	596	P51825
KPKKVKTLSGNRIKS	SINHCAF	91	Q9NP50
RGKKSVKLSLNPKNV	PDCD11	161	Q14690
RGAITQPLKKLKINV	ZNF532	1156	Q9HCE3
RLSKKKKNTQGLQVP	TRPM6	1581	Q9BX84
PGNKQAVTELSKIKK	RPAP3	381	Q9H6T3
LSQVKKGKAITPKDN	SUV39H2	101	Q9H5I1
QQIKTRPRKIKKDGK	PRPF38B	231	Q5VTL8
IAKSITKVGQKKTPA	HEATR9	521	A2RTY3
VSQKKRKIAVVQPEK	SFMBT2	481	Q5VUG0
AKSQPLVQEKKRVVK	WASHC2C	891	Q9Y4E1
KTKKRTKTIFGNLNP	UNC13B	631	O14795
QVTVLQAKDLKPKGK	RAB11FIP2	16	Q7L804
VVEKKRPGKLNAQKL	ELAC1	191	Q9H777
KTEKLKQEQKGQPRT	VCPIP1	731	Q96JH7
SKRCQSGQKKKPVGI	TAS1R2	496	Q8TE23
PEIKLKITKTIQNGR	NSD3	151	Q9BZ95
KTIGNRKKKTLTLPF	ZNF770	396	Q6IQ21
LKQRLQGTDIPTVKK	ZC2HC1B	51	Q5TFG8
QKREPGTKTKKQTTL	TOP2A	1266	P11388
KKQSNTGRVQPSKRK	TXK	56	P42681
AKSQPLVQEKKRVVK	WASHC2A	891	Q641Q2
TTLKLVKGQFPQKRK	TASOR2	386	Q5VWN6
VKKSPQKQRVNIVKG	TASOR2	456	Q5VWN6
VRGQTPKVAKQEKKK	FAU	86	P62861
KKQKTEQLGLTRTPI	WDR12	236	Q9GZL7
QQVTKKKQELGKGLP	ZNF106	796	Q9H2Y7
LKAKGRISKKLTAPQ	TFIP11	246	Q9UBB9
LKGKRKETLKNVPFS	ZNF638	1561	Q14966
KRKQKTFIVKPANGA	TTLL7	151	Q6ZT98
GLVPKKKQSVVQEKK	TTF2	181	Q9UNY4
TQRVILKKKEPGKRS	VPS13D	3631	Q5THJ4
QGSKRKPRKLGQIKV	MYO3B	1286	Q8WXR4
QKPRAFILKSKGIKQ	MYO9B	771	Q13459